Vanda Pharmaceuticals to Announce Third Quarter 2022 Financial Results on November 2, 2022PRNewsWire • 10/26/22
Vanda Pharmaceuticals Announces Orphan Drug Designation Granted for VPO-227, a Novel Candidate for the Treatment of CholeraPRNewsWire • 10/21/22
Vanda Pharmaceuticals and OliPass Announce Strategic Partnership to Develop Antisense Oligonucleotide TherapeuticsPRNewsWire • 09/29/22
Vanda Pharmaceuticals Announces Participation in the H.C. Wainwright Global Investment ConferencePRNewsWire • 09/08/22
VANDA PHARMACEUTICALS ANNOUNCES NOTICE OF OPPORTUNITY FOR AN FDA HEARING ON THE sNDA FOR HETLIOZ® IN JET LAG DISORDERPRNewsWire • 09/07/22
Vanda Pharmaceuticals (VNDA) Q2 Earnings and Revenues Miss EstimatesZacks Investment Research • 08/03/22
Vanda Pharmaceuticals Inc. (VNDA) CEO Mihael Polymeropoulos on Q2 2022 Results - Earnings Call TranscriptSeeking Alpha • 08/03/22
Vanda Pharmaceuticals to Announce Second Quarter 2022 Financial Results on August 3, 2022PRNewsWire • 07/27/22
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Vanda Pharmaceuticals Inc.Newsfile Corp • 07/01/22
Vanda Pharmaceuticals Announces Participation in the Jefferies 2022 Global Healthcare ConferencePRNewsWire • 06/02/22
Vanda Pharmaceuticals: Strong Pipeline Developments To Power Long-Term UpsideSeeking Alpha • 05/17/22
Vanda Pharmaceuticals (VNDA) Reports Q1 Loss, Tops Revenue EstimatesZacks Investment Research • 05/06/22
Vanda Pharmaceuticals Inc. (VNDA) CEO Mihael H. Polymeropoulos on Q1 2022 Results - Earnings Call TranscriptSeeking Alpha • 05/05/22
Vanda Pharmaceuticals Announces Participation in the BofA Securities 2022 Healthcare ConferencePRNewsWire • 05/04/22
Vanda Pharmaceuticals to Announce First Quarter 2022 Financial Results on May 5, 2022PRNewsWire • 04/28/22
Earnings Preview: Vanda Pharmaceuticals (VNDA) Q1 Earnings Expected to DeclineZacks Investment Research • 04/27/22
Vanda Pharmaceuticals Inc. (VNDA) CEO Mihael Polymeropoulos on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha • 02/24/22
Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial ResultsPRNewsWire • 02/23/22